NCT00667121 2025-02-14
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Mayo Clinic
Completed
Clinical Trials
10 trialsNCT04977271 2025-02-04
Mood Disorders in Head and Neck Cancer Patients
University of Alabama at Birmingham
Phase 4 Withdrawn
NCT06106529 2025-02-04
REDFLASH
Reinier de Graaf Groep
Phase 3 Recruiting
NCT05724849 2024-01-18
Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer
Vanderbilt University Medical Center
Phase 2 Withdrawn
NCT06131268 2023-11-14
RONIN
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Phase 4 Unknown
NCT03574792 2021-12-09
Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy
Roswell Park Cancer Institute
Phase NA Completed
NCT00354432 2021-09-28
Soy Protein/Effexor Hormone Therapy for Prostate Cancer
Wake Forest University Health Sciences
Phase 3 Terminated
NCT01533753 2019-11-21
Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer
University of Wisconsin, Madison
Phase 2 Terminated
NCT00084669 2010-04-28
Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer
Massachusetts General Hospital
Phase NA Completed
NCT00198250 2008-11-14
Venlafaxine for Hot Flashes After Breast Cancer
Indiana University
Phase 2 Completed